Interesting sales technique - buy our IP or we'll sell it to someone else ... but we're not selling exclusive licences.
I would be surprised if our marketing team were not explaining the benefits of Alida to potential customers.
There's an old saying about leading a horse to water.
The process of developing a new product, especially in safety-critical applications like ADAS, is a long term project. Even an IC manufacturer like Renesas has taken more than 2 years to produce the hardware. We're hoping Valeo will incorporate Akida in SCALA 3 next year, after more than 2.5 years of joint development.
https://smallcaps.com.au/brainchip-joint-development-agreement-akida-neuromorphic-chip-valeo/
We have partnerships with several leading edge start-ups as well as the titans of the industry.
In the last 12 months, business conditions have taken a turn for the worse: inflation, recession, component shortages, war, layoffs in the major companies, cost cutting and belt tightening across the board, bear market ...
Am I happy about the delay? I bought in FOMO in 2018 when I first discovered BRN and saw they were due to make a presentation to an engineering conference in the US in a couple of weeks. I was sure the SP would hit $17.85* in no time.
The whole business strategy has been overhauled in the interim, but the underlying brilliance of our product has only got brillianter. We're not selling psilocybin - this is a real trip to the moon.
*There were fewer shares then.